PMI03

PRECISION MOLECULAR

Drug Candidate

PMI03

Summary

Potential first-in-class imaging agent for neuroinflammation/neurodegenerative diseases

Mechanism of Action

PET ligand targeting sEH

Indication

PET Tracer for neuroinflammation

Development Stage

Phase I